Discontinuation of antimicrobial stewardship programs (ASPs) and increased antibiotic use were described during SARS-CoV-2 pandemic. In order to measure COVID-19 impact on ASPs in a setting of high multidrug resistance organisms (MDRO) prevalence, a qualitative survey was designed. In July 2021, eighteen ID Units were asked to answer a questionnaire about their hospital characteristics, ASPs implementation status before the pandemic and impact of SARS-CoV-2 pandemic on ASPs after the 1st and 2nd pandemic waves in Italy. Nine ID centres (50%) reported a reduction of ASPs and in 7 cases (38.9%) these were suspended. After the early pandemic waves, the proportion of centres that restarted their ASPs was higher among the ID centres where antimicrobial stewardship was formally identified as a priority objective (9/11, 82%, vs 2/7, 28%). SARS-CoV-2 pandemic had a severe impact in ASPs in a region highly affected by COVID-19 and antimicrobial resistance but weaknesses related to the pre-existent ASPs might have played a role.

What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres / A. Comelli, C. Genovese, A. Lombardi, C. Bobbio, L. Scudeller, U. Restelli, A. Muscatello, S. Antinori, P. Bonfanti, S. Casari, A. Castagna, F. Castelli, A.D. Monforte, F. Franzetti, P. Grossi, M. Lupi, P. Morelli, S. Piconi, M. Puoti, L. Pusterla, A. Regazzetti, M. Rizzi, S. Rusconi, V. Zuccaro, A. Gori, A. Bandera. - In: ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL. - ISSN 2047-2994. - 11:1(2022), pp. 108.1-108.7. [10.1186/s13756-022-01152-5]

What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres

C. Genovese
Secondo
;
A. Lombardi;S. Antinori;A.D. Monforte;S. Rusconi;A. Gori
Penultimo
;
A. Bandera
Ultimo
2022

Abstract

Discontinuation of antimicrobial stewardship programs (ASPs) and increased antibiotic use were described during SARS-CoV-2 pandemic. In order to measure COVID-19 impact on ASPs in a setting of high multidrug resistance organisms (MDRO) prevalence, a qualitative survey was designed. In July 2021, eighteen ID Units were asked to answer a questionnaire about their hospital characteristics, ASPs implementation status before the pandemic and impact of SARS-CoV-2 pandemic on ASPs after the 1st and 2nd pandemic waves in Italy. Nine ID centres (50%) reported a reduction of ASPs and in 7 cases (38.9%) these were suspended. After the early pandemic waves, the proportion of centres that restarted their ASPs was higher among the ID centres where antimicrobial stewardship was formally identified as a priority objective (9/11, 82%, vs 2/7, 28%). SARS-CoV-2 pandemic had a severe impact in ASPs in a region highly affected by COVID-19 and antimicrobial resistance but weaknesses related to the pre-existent ASPs might have played a role.
Antimicrobial stewardship; Antimicrobials use; COVID-19; Multidrug resistant organisms; SARS-CoV-2; Humans; Pandemics; SARS-CoV-2; Surveys and Questionnaires; Antimicrobial Stewardship; COVID-19; Communicable Diseases
Settore MED/17 - Malattie Infettive
Article (author)
File in questo prodotto:
File Dimensione Formato  
What is the impact of SARS-CoV-2 pandemic on ASPs_Antimicrobial Resistance and Infection Control 2022.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.27 MB
Formato Adobe PDF
1.27 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/940007
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact